Serafin Andrew's most recent trade in Harmony Biosciences Holdings Inc was a trade of 36,500 Stock Option done . Disclosure was reported to the exchange on Jan. 24, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Harmony Biosciences Holdin...
|
Andrew Serafin | CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 36,500 | 36,500 | - | - | Stock Option | |
Harmony Biosciences Holdin...
|
Andrew Serafin | CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 10,400 | 10,400 | - | - | Restricted Stock Units | |
Harmony Biosciences Holdin...
|
Andrew Serafin | CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 2,500 | 2,500 | - | 0 | Common Stock | |
Harmony Biosciences Holdin...
|
Andrew Serafin | CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 2,500 | 7,500 | - | - | Restricted Stock Units | |
Harmony Biosciences Holdin...
|
Andrew Serafin | CHIEF STRATEGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.01 per share. | 24 Jan 2025 | 865 | 1,635 | - | 38.0 | 32,879 | Common Stock |
Harmony Biosciences Holdin...
|
Serafin Andrew | CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 47,750 | 47,750 | - | - | Stock Option | |
Harmony Biosciences Holdin...
|
Serafin Andrew | CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 10,000 | 10,000 | - | - | Restricted Stock Unit | |
Harmony Biosciences Holdin...
|
Andrew Serafin | CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 38,000 | 83,729 | - | - | Stock Option | |
Harmony Biosciences Holdin...
|
Andrew Serafin | CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 02 Dec 2022 | 38,000 | 38,000 | - | 8.2 | 312,360 | Common Stock |
Harmony Biosciences Holdin...
|
Andrew Serafin | CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 60.12 per share. | 02 Dec 2022 | 37,080 | 920 | - | 60.1 | 2,229,246 | Common Stock |
Harmony Biosciences Holdin...
|
Andrew Serafin | CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 60.71 per share. | 02 Dec 2022 | 920 | 0 | - | 60.7 | 55,854 | Common Stock |
Harmony Biosciences Holdin...
|
Andrew Serafin | Chief Business Officer | 21 Aug 2020 | 200,000 | 0 | - | - | Series A Preferred Stock | ||
Harmony Biosciences Holdin...
|
Andrew Serafin | Chief Business Officer | 21 Aug 2020 | 51,021 | 0 | - | - | Series C Preferred Stock | ||
Harmony Biosciences Holdin...
|
Andrew Serafin | Chief Business Officer | 21 Aug 2020 | 33,693 | 33,693 | - | - | Common Stock | ||
Harmony Biosciences Holdin...
|
Andrew Serafin | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2020 | 81,875 | 81,875 | - | - | Stock Option |